Currently predicting for Thu, 4 Jun 2026

GERN Prediction Chart

GERN Predictions History

Latest community submissions for GERN.
Predictor Target Session Target Price Result Direction Accuracy Score
Jul 7, 2023 $3.10 -1.24% $3.14 X 98.76% 1
Jul 7, 2023 $3.08 -2.84% $3.14 V 98.09% 0
Jul 3, 2023 $3.14 -2.05% $3.18 V 98.87% 2
Jul 3, 2023 $3.17 -1.28% $3.18 V 99.65% 5
JS JS Pro
Jul 3, 2023 $3.24 +0.93% $3.18 X 98.11% 0
Jun 7, 2023 $3.53 -1.88% $3.56 V 99.22% 3
Jun 7, 2023 $3.56 -1.17% $3.56 V 99.94% 10
Jun 7, 2023 $3.80 +5.56% $3.56 X 93.26% 0
Jun 6, 2023 $3.55 -1.86% $3.60 V 98.68% 2
Jun 6, 2023 $3.58 -1.17% $3.60 V 99.38% 4
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for GERN with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT GERON CORPORATION
Geron
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes a...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE